Skip to content

Clinical trials

Phase 1/2 Hematologic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20101
20111
20132
20141
20173
20194
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Unknown status3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
A.O. Ospedale Papa Giovanni XXIII2
AstraZeneca2
Bellicum Pharmaceuticals2
AGC Biologics S.p.A.1
Clavis Pharma1
Curis, Inc.1
Daiichi Sankyo1
European Myeloma Network B.V.1
Gamida Cell ltd1
Genenta Science1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms17
Leukemia4
Leukemia, Myeloid, Acute4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Lymphoma, Non-Hodgkin3
Myelodysplastic Syndromes3
Neoplasms3
Anemia2
Anemia, Aplastic2
Anemia, Diamond-Blackfan2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.